11th May 2026 07:56
(Alliance News) - Compass Group raised annual profit guidance after reporting double-digit first-half operating profit growth, while GSK announced a China partnership for hepatitis B treatment bepirovirsen and the final tranche of its GBP2 billion buyback. Elsewhere, Victrex warned higher energy costs linked to the Middle East conflict could weigh on demand as interim profit declined. Read More
